Further analysis revealed that the increased CD8 TILs in CP1-administered tumors expressed increased TNFα (Fig. 3c) and the activation marker PD-1 (Fig. 3d), and a higher percentage expressed IFNγ within the tumor draining lymph nodes (dLNs) (Fig. 3e). The gene discussed is IFNG; the disease is neoplasm.